Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#111 / 200 Total
HUMA - Humacyte Inc - Stock Price Chart
TickerHUMA [NASD, RUT]
CompanyHumacyte Inc
CountryUSA
IndustryBiotechnology
Market Cap358.32MEPS (ttm)-0.69
P/E-EPS this Y80.49%
Forward P/E-EPS next Y-14.69%
PEG-EPS past 5Y42.43%
P/S689.08EPS next 5Y-
P/B9.94EPS Q/Q194.67%
Dividend-Sales Q/Q-
Insider Own19.13%Inst Own39.93%
Insider Trans0.36%Inst Trans43.73%
Short Float24.38%EarningsMay 13/b
Analyst Recom1.29Target Price9.43
Avg Volume4.03M52W Range1.15 - 9.79
Humacyte, Inc. engages in the business of developing and manufacturing off-the-shelf, universally implantable, bioengineered human tissues, advanced tissue constructs, and organ systems with the goal of improving the lives of patients and transforming the practice of medicine. The company was founded by Laura E. Niklason, Shannon Dahl, and Juliana L. Blum on October 13, 2004 and is headquartered in Durham, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Scheessele William JohnChief Commercial OfficerApr 14 '25Buy1.546,4939,99922,018Apr 15 04:03 PM
Sander Dale A.CFO and Chief Corp. Deve. Off.Apr 10 '25Buy1.5320,00030,60040,600Apr 14 09:00 AM
Parikh Shamik JChief Medical OfficerApr 10 '25Buy1.557,50011,6257,500Apr 14 09:00 AM
Sebelius KathleenDirectorApr 08 '25Buy1.3250,00066,00091,207Apr 08 04:15 PM
Green Charles BruceDirectorApr 08 '25Buy1.296,0007,7408,400Apr 08 04:15 PM
WEAV - Weave Communications Inc - Stock Price Chart
TickerWEAV [NYSE, RUT]
CompanyWeave Communications Inc
CountryUSA
IndustryHealth Information Services
Market Cap581.91MEPS (ttm)-0.41
P/E-EPS this Y9.23%
Forward P/E54.78EPS next Y158.68%
PEG-EPS past 5Y5.67%
P/S2.73EPS next 5Y84.01%
P/B8.45EPS Q/Q-17.03%
Dividend-Sales Q/Q18.31%
Insider Own14.45%Inst Own81.32%
Insider Trans-9.47%Inst Trans9.16%
Short Float4.65%EarningsMay 05/a
Analyst Recom1.57Target Price14.14
Avg Volume828.75K52W Range7.91 - 17.63
Weave Communications, Inc. develops a customer communication platform for service-based businesses. It offers voice, short message service, email and marketing services to dental, optometry, medical, and veterinary offices. The company was founded by Clint Berry, Brandon Rodman, and Jared Rodman in September 2008 and is headquartered in Lehi, UT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Christiansen Jason PaulChief Financial OfficerJun 16 '25Sale8.594,07034,961324,938Jun 20 04:14 PM
Christiansen Jason PaulChief Financial OfficerJun 17 '25Sale8.483,94033,411320,998Jun 20 04:14 PM
Christiansen Jason PaulOfficerJun 20 '25Proposed Sale8.483,94033,411Jun 20 11:13 AM
Christiansen Jason PaulOfficerJun 20 '25Proposed Sale8.594,07034,943Jun 20 10:59 AM
Bertilson MarcusChief Operating OfficerJun 17 '25Sale8.5311,40997,319352,093Jun 18 04:25 PM
PSNL - Personalis Inc - Stock Price Chart
TickerPSNL [NASD, RUT]
CompanyPersonalis Inc
CountryUSA
IndustryDiagnostics & Research
Market Cap562.63MEPS (ttm)-1.29
P/E-EPS this Y30.93%
Forward P/E-EPS next Y2.25%
PEG-EPS past 5Y-11.31%
P/S6.57EPS next 5Y16.56%
P/B2.71EPS Q/Q29.62%
Dividend-Sales Q/Q5.53%
Insider Own40.29%Inst Own36.44%
Insider Trans-0.01%Inst Trans11.47%
Short Float11.64%EarningsMay 06/a
Analyst Recom1.25Target Price7.25
Avg Volume1.08M52W Range1.52 - 7.79
Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in February 2011 and is headquartered in Fremont, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tachibana AaronCFO AND COOMay 16 '25Sale4.951,2916,390165,099May 20 05:53 PM
Moore Stephen MichaelSVP and Chief Legal OfficerMay 16 '25Sale4.951,6758,29164,200May 20 05:51 PM
Chen RichardCHIEF MEDICAL OFFICER AND EVPMay 16 '25Sale4.959104,504124,957May 20 05:50 PM
Tachibana AaronCFO AND COOJan 28 '25Sale5.797084,099166,390Jan 30 05:01 PM
Chen RichardCHIEF MEDICAL OFFICER AND EVPJan 28 '25Sale5.795193,005123,367Jan 30 04:59 PM
KIDZ - Classover Holdings Inc - Stock Price Chart
TickerKIDZ [NASD]
CompanyClassover Holdings Inc
CountryUSA
IndustryEducation & Training Services
Market Cap74.47MEPS (ttm)-0.15
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S44.07EPS next 5Y-
P/B-EPS Q/Q-114.70%
Dividend-Sales Q/Q-
Insider Own71.20%Inst Own1.85%
Insider Trans0.00%Inst Trans-
Short Float2.02%Earnings-
Analyst Recom-Target Price-
Avg Volume9.13M52W Range1.03 - 12.00
Classover Holdings, Inc. operates as a blank check company. It provides comprehensive online interactive live courses for K-12 students in the United States and around the globe. The company was founded on May 2, 2024 and is headquartered in New York, NY.
STRS - Stratus Properties Inc - Stock Price Chart
TickerSTRS [NASD, RUT]
CompanyStratus Properties Inc
CountryUSA
IndustryReal Estate - Diversified
Market Cap153.30MEPS (ttm)-0.68
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S4.69EPS next 5Y-
P/B0.80EPS Q/Q-164.05%
Dividend-Sales Q/Q-80.97%
Insider Own18.50%Inst Own51.06%
Insider Trans-0.34%Inst Trans-9.78%
Short Float1.10%Earnings-
Analyst Recom-Target Price-
Avg Volume11.74K52W Range15.10 - 30.66
Stratus Properties, Inc. engages in the acquisition, development, and management of real estate assets. It operates through the following segments: Hotel, Entertainment, Real Estate Operations, and Leasing Operations. The Hotel segment manages W Austin Hotel and Residences. The Entertainment segment includes production studios and venues for live music, concerts, and private events. The Real Estate Operations segment pertains to the firm's residential properties. The Leasing Operations segment offers office buildings and retail spaces. The company was founded on March 11, 1992 and is headquartered in Austin, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
JOSEPH JAMESDirectorJul 02 '25Sale18.825,00094,10015,715Jul 07 04:38 PM
Oasis Management Co Ltd.10% OwnerMay 20 '25Sale21.04651,3681,136,891May 22 04:10 PM
Oasis Management Co Ltd.10% OwnerMay 21 '25Sale21.55153231,136,876May 22 04:10 PM
Oasis Management Co Ltd.10% OwnerNov 25 '24Sale27.001734,6711,136,956Nov 27 06:01 PM
Oasis Management Co Ltd.10% OwnerNov 22 '24Sale27.002,02254,5941,137,129Nov 25 04:25 PM
FBRX - Forte Biosciences Inc - Stock Price Chart
TickerFBRX [NASD]
CompanyForte Biosciences Inc
CountryUSA
IndustryBiotechnology
Market Cap128.86MEPS (ttm)-13.81
P/E-EPS this Y64.03%
Forward P/E-EPS next Y26.96%
PEG-EPS past 5Y24.08%
P/S-EPS next 5Y41.96%
P/B1.81EPS Q/Q65.88%
Dividend-Sales Q/Q-
Insider Own19.08%Inst Own46.68%
Insider Trans0.00%Inst Trans32.41%
Short Float1.38%EarningsMay 15/a
Analyst Recom1.00Target Price45.67
Avg Volume91.68K52W Range4.11 - 28.68
Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. The firm's lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis. The company was founded by Paul A. Wagner in 2017 and is headquartered in Dallas, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Riley Antony ACHIEF FINANCIAL OFFICERJul 01 '25Option Exercise0.00375031,733Jul 03 04:22 PM
Wagner Paul A.SEE REMARKSJul 01 '25Option Exercise0.001,250081,038Jul 03 04:20 PM
Riley Antony ACHIEF FINANCIAL OFFICERApr 01 '25Option Exercise0.00375031,372Apr 02 05:03 PM
Wagner Paul A.SEE REMARKSApr 01 '25Option Exercise0.001,250079,806Apr 02 05:01 PM
Riley Antony ACHIEF FINANCIAL OFFICERJan 01 '25Option Exercise0.00375031,151Jan 02 05:10 PM
DTIL - Precision Biosciences Inc - Stock Price Chart
TickerDTIL [NASD]
CompanyPrecision Biosciences Inc
CountryUSA
IndustryBiotechnology
Market Cap49.34MEPS (ttm)-2.01
P/E-EPS this Y-749.36%
Forward P/E-EPS next Y25.81%
PEG-EPS past 5Y-
P/S0.96EPS next 5Y-
P/B0.95EPS Q/Q-230.49%
Dividend-Sales Q/Q-99.84%
Insider Own26.99%Inst Own34.11%
Insider Trans-1.83%Inst Trans12.42%
Short Float16.03%EarningsMay 15/b
Analyst Recom1.00Target Price34.33
Avg Volume257.60K52W Range3.61 - 11.09
Precision BioSciences, Inc. is a biotechnology company, which engages in the development of genome editing technologies. It operates through the Therapeutics and Food segments. The Therapeutics segment focuses on the development of products in the field of immuno-oncology and of novel products outside immuno-oncology to treat human diseases. The Food segment applies ARCUS, the company's proprietary genome editing platform, to develop food and nutrition products through collaboration agreements with consumer-facing companies. The company was founded by Derek N. Jantz, Jeff Smith, and Matthew R. Kane on January 26, 2006 and is headquartered in Durham, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kelly John AlexanderChief Financial OfficerJul 03 '25Sale4.2614,82763,16373,485Jul 08 04:30 PM
Kelly John AlexanderOfficerJul 03 '25Proposed Sale4.2614,82763,208Jul 03 03:25 PM
Brown MelindaDirectorJun 25 '25Buy4.141,6826,96320,565Jun 27 06:14 AM
Buehler KevinDirectorJun 25 '25Buy4.165,07621,11628,137Jun 27 06:14 AM
Buehler KevinDirectorMar 26 '25Buy4.674,52321,12213,235Mar 28 07:02 AM
ANNX - Annexon Inc - Stock Price Chart
TickerANNX [NASD, RUT]
CompanyAnnexon Inc
CountryUSA
IndustryBiotechnology
Market Cap283.06MEPS (ttm)-1.17
P/E-EPS this Y-45.07%
Forward P/E-EPS next Y1.20%
PEG-EPS past 5Y-0.09%
P/S-EPS next 5Y2.82%
P/B1.16EPS Q/Q-78.85%
Dividend-Sales Q/Q-
Insider Own12.93%Inst Own87.98%
Insider Trans-0.27%Inst Trans-5.70%
Short Float10.52%EarningsMay 12/b
Analyst Recom1.00Target Price11.60
Avg Volume1.63M52W Range1.28 - 7.85
Jun-18-25 04:05PM Annexon Bolsters Ophthalmology Expertise with Appointment of Retina Specialist Lloyd Clark, M.D., as Pivotal ANX007 Program Advances in Dry Age-Related Macular Degeneration (AMD) with Geographic Atrophy (GA) (GlobeNewswire)
May-29-25 04:05PM Annexon Biosciences to Present at the Jefferies Global Healthcare Conference (GlobeNewswire) +7.39% -6.42%
May-19-25 04:05PM Annexon Showcases Tanruprubart Data Demonstrating Improved Clinical Outcomes in Guillain-Barré Syndrome (GBS) at 2025 Peripheral Nerve Society (PNS) Annual Meeting (GlobeNewswire)
04:05PM Annexon Showcases Tanruprubart Data Demonstrating Improved Clinical Outcomes in Guillain-Barre Syndrome (GBS) at 2025 Peripheral Nerve Society (PNS) Annual Meeting (GlobeNewswire)
May-16-25 04:05PM Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +11.05%
May-12-25 08:00AM Annexon Reports First Quarter 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones (GlobeNewswire) +10.62%
May-09-25 05:00PM Annexon Announces Presentations on the Clinical Advancement of Tanruprubart as the First Potential Targeted Therapy for Guillain-Barré Syndrome (GBS) at the 2025 PNS Meeting (GlobeNewswire) -5.88%
05:00PM Annexon Announces Presentations on the Clinical Advancement of Tanruprubart as the First Potential Targeted Therapy for Guillain-Barre Syndrome (GBS) at the 2025 PNS Meeting (GlobeNewswire)
May-07-25 08:00AM Annexon to Present on the Neuroprotective Effects of ANX007 at the 2025 ARVO Annual Meeting and the Retina World Congress (GlobeNewswire)
Apr-16-25 04:05PM Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -7.14%
Annexon, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain. It offers drugs that control or target huntington's and alzheimer's disease, multiple sclerosis, glaucoma, parkinson's disease, and spinal muscular atrophy. The company was founded by Ben Barres and Arnon Rosenthal on March 3, 2011 and is headquartered in Brisbane, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Carson William H.DirectorJun 30 '25Buy2.464,11510,12329,715Jul 01 04:55 PM
Dananberg JamieCHIEF MEDICAL OFFICERFeb 18 '25Sale2.965,52116,34233,479Feb 20 04:54 PM
ARTIS DEAN RICHARDEVP & CHIEF SCIENTIFIC OFFICERFeb 18 '25Sale2.975,51516,38083,814Feb 20 04:52 PM
Yednock TedEVP & CHIEF INNOVATION OFFICERFeb 18 '25Sale2.918,34524,28461,237Feb 20 04:51 PM
Overdorf MichaelEVP & CHIEF BUSINESS OFFICERFeb 18 '25Sale2.956,61819,52386,579Feb 20 04:49 PM
DUO - Fangdd Network Group Ltd - Stock Price Chart
TickerDUO [NASD]
CompanyFangdd Network Group Ltd
CountryChina
IndustryReal Estate Services
Market Cap8.94MEPS (ttm)0.84
P/E2.66EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.19EPS next 5Y-
P/B0.09EPS Q/Q-10593.67%
Dividend-Sales Q/Q-81.26%
Insider Own2.55%Inst Own7.91%
Insider Trans0.00%Inst Trans-44.61%
Short Float5.05%Earnings-
Analyst Recom3.00Target Price168.83
Avg Volume333.19K52W Range1.97 - 74.72
Fangdd Network Group Ltd. is an investment holding company, which engages in the provision of real estate information services through its online platform. It also offers integrated marketing services for individual customers, real estate developers, and agents. The company was founded by Yi Duan, Xi Zeng, and Jian Cheng Li in October 2011 and is headquartered in Shenzhen, China.
ASPS - Altisource Portfolio Solutions S.A - Stock Price Chart
TickerASPS [NASD]
CompanyAltisource Portfolio Solutions S.A
CountryLuxembourg
IndustryReal Estate Services
Market Cap140.21MEPS (ttm)-8.12
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y42.14%
P/S0.81EPS next 5Y-
P/B-EPS Q/Q71.83%
Dividend-Sales Q/Q9.29%
Insider Own15.98%Inst Own48.02%
Insider Trans32.63%Inst Trans6.36%
Short Float2.76%EarningsMay 01/b
Analyst Recom2.00Target Price80.00
Avg Volume37.20K52W Range3.46 - 14.48
Altisource Portfolio Solutions SA engages in the provision of integrated service and marketplace for the real estate and mortgage industries. It operates through the following businesses: field services, marketplace, and mortgage and real estate solutions. The field services segment is involved in property preservation and inspection services, and vendor management oversight software-as-a-service (SaaS) platform. The marketplace business offers Hubzu, an online real estate auction platform, real estate auction, real estate brokerage, and asset management; and Equator, a SaaS-based technology to manage real estate owned, short sales, foreclosure, bankruptcy, and eviction processes. The mortgage and real estate solutions business includes mortgage loans, title insurance, real estate valuation services, residential and commercial construction inspection and risk mitigation services, foreclosure trustee services, and management of Lenders One. The company was founded on November 4, 1999 and is headquartered in Luxembourg.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RITTS GREGORY J.Chief Legal/Compliance OfficerApr 09 '25Buy0.4820,0009,600272,041Apr 09 12:51 PM
Shepro William BChairman and CEOMar 28 '25Buy0.48210,498101,039310,498Apr 01 04:14 PM
Esterman Michelle D.Chief Financial OfficerMar 28 '25Buy0.48210,498101,039662,250Apr 01 04:12 PM
Esterman Michelle D.Chief Financial OfficerMar 20 '25Option Exercise0.009,9650454,706Mar 24 06:34 PM
RITTS GREGORY J.Chief Legal/Compliance OfficerMar 20 '25Option Exercise0.009,0370256,288Mar 24 06:33 PM
1789101112131415161720